PEREGRINE CAPITAL MANAGEMENT LLC - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 212 filers reported holding IMMUNOMEDICS INC in Q3 2019. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.

Quarter-by-quarter ownership
PEREGRINE CAPITAL MANAGEMENT LLC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q2 2020$14,977,000
+46.7%
422,602
-44.2%
0.43%
+16.4%
Q1 2020$10,208,000
-29.8%
757,275
+10.2%
0.37%
-1.1%
Q4 2019$14,534,000
+27.4%
686,873
-20.2%
0.37%
+19.4%
Q3 2019$11,412,000860,6230.31%
Other shareholders
IMMUNOMEDICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 17,714,461$368,992,00016.94%
ACUTA CAPITAL PARTNERS, LLC 2,055,500$42,816,00015.27%
Foresite Capital Management III, LLC 2,691,729$56,069,00012.37%
Foresite Capital Management IV, LLC 1,231,543$25,653,0008.41%
NEXTHERA CAPITAL LP 1,398,577$29,132,0005.58%
Palo Alto Investors LP 5,013,764$104,437,0004.22%
Ghost Tree Capital, LLC 883,823$18,410,0003.91%
First Light Asset Management, LLC 1,151,622$23,988,0003.87%
DLD Asset Management, LP 3,403,000$70,918,0003.51%
RA Capital Management 3,119,778$64,985,0003.47%
View complete list of IMMUNOMEDICS INC shareholders